Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Winqvist · SciRah

Researcher profile · Semantic Scholar

M. Winqvist

Share profile

M. Winqvist — researcher profile on SciRah

h-index: 6
Works: 14
Citations: 224

Most-cited papers

Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group
M. Winqvist, A. Asklid, P. Andersson, K. Karlsson +8 more
2016Haematologica119 citations Open access
Semantic Scholar
Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort
M. Winqvist, P. Andersson, A. Asklid, K. Karlsson +10 more
2018Haematologica61 citations Open access
Semantic Scholar
Risk‐adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real‐world report on 141 consecutive Swedish patients
Agnes Mattsson, S. E. Sylvan, A. Asklid, J. Wiggh +7 more
2020British Journal of Haematology10 citations Open access
Semantic Scholar
Phase I–II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints
M. Winqvist, F. Mozaffari, M. Palma, Sandra Eketorp Sylvan +4 more
2016Cancer Immunology and Immunotherapy9 citations Open access
Semantic Scholar
Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Data from 97 Swedish Patients Treated in a Compassionate Use Program
L. Hansson, M. Winqvist, A. Asklid, P. Andersson +8 more
20157 citations
Semantic Scholar
Outcomes of second-line treatment in chronic lymphocytic leukemia – a population-based study from a well defined geographical region between 2003 and 2013
A. Asklid, M. Winqvist, Sandra Eketorp Sylvan, Agnes Mattsson +6 more
2017Leukemia and Lymphoma6 citations
Semantic Scholar
A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapy
A. Asklid, Sandra Eketorp Sylvan, Agnes Mattsson, M. Winqvist +3 more
2020Leukemia and Lymphoma5 citations
Semantic Scholar
Dual targeting of Bruton tyrosine kinase and CD52 induces minimal residual disease‐negativity in the bone marrow of poor‐prognosis chronic lymphocytic leukaemia patients but is associated with opportunistic infections – Results from a phase I study
M. Winqvist, M. Palma, K. Heimersson, H. Mellstedt +2 more
2018British Journal of Haematology4 citations Open access
Semantic Scholar
In Vivo Effects of Lenalidomide on T Cell Proliferation and Immune Checkpoint Molecules in Patients with Advanced Stage CLL: Results from a Phase II Study
M. Winqvist, F. Mozaffari, M. Palma, S. E. Sylvan +3 more
20153 citations
Semantic Scholar
Outcome of Second Line Treatment in Patients with Chronic Lymphocytic Leukemia Did Not Improve 2002-2013: A Population-Based Study from a Well-Defined Geographic Region
A. Asklid, Agnes Mattsson, Einar Björgvinsson, M. Winqvist +6 more
20151 citations
Semantic Scholar
Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study.
Shuo Ma, S. Rosen, M. Winqvist, O. Frankfurt +8 more
2022Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis0 citations
Semantic Scholar
Targeted therapy in chronic lymphocytic leukemia
M. Winqvist
20200 citations
Semantic Scholar
Peer Review #1 of "RITAN: rapid integration of term annotation and network resources (v0.1)"
M. Zimmermann, B. Kabat, D. Grill, R. Kennedy +484 more
20190 citations Open access
Semantic Scholar
Monitoring of hemolytic activity of serum during alemtuzumab/ofatumumab therapy of chronic lymphocytic leukemia
Grzegorz Stasiłojć, M. Winqvist, A. Blom, A. Österborg +1 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Österborg×12
Invite
A. Österborg — researcher profile on SciRah
J. Lundin×8
Invite
J. Lundin — researcher profile on SciRah
L. Hansson×8
Invite
L. Hansson — researcher profile on SciRah
A. Asklid×7
Invite
A. Asklid — researcher profile on SciRah

×4

Invite

Agnes Mattsson — researcher profile on SciRah

Invite

K. Karlsson — researcher profile on SciRah

Invite

C. Karlsson — researcher profile on SciRah

Invite

B. Lauri — researcher profile on SciRah

Invite

M. Mattsson — researcher profile on SciRah

Invite

S. Norin — researcher profile on SciRah

A. Sandstedt×3

Invite

A. Sandstedt — researcher profile on SciRah

S. E. Sylvan×3

Invite

S. E. Sylvan — researcher profile on SciRah